Patents by Inventor Ying Tang

Ying Tang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20100260752
    Abstract: This invention provides binding molecules with improved binding affinity to lipoteichoic acids exposed on the surface of the bacteria, useful in the prevention and treatment of infections caused by Gram positive bacteria.
    Type: Application
    Filed: January 22, 2010
    Publication date: October 14, 2010
    Applicant: Biosynexus Incorporated
    Inventor: Ying TANG
  • Patent number: 7794795
    Abstract: The present invention relates to a coating composition including a sol-gel matrix and a dendrimeric organochalcogeno derivative and a system including the coating composition and a substrate. The present invention also relates to a method of preventing fouling of surfaces subjected to a marine environment.
    Type: Grant
    Filed: July 6, 2007
    Date of Patent: September 14, 2010
    Assignee: The Research Foundation of State University of New York
    Inventors: Michael R. Detty, Michael D. Drake, Ying Tang, Frank V. Bright
  • Patent number: 7763248
    Abstract: The invention provides a grafted antibody, or functional fragment thereof, comprising one or more complementarity determining regions (CDRs) having at least one amino acid substitution in one or more CDRs of a heavy chain CDR, where the grafted antibody or functional fragment thereof has specific binding activity for a cryptic collagen epitope. The invention also provides methods of using an antibody having specific binding activity for a cryptic collagen epitope, including methods of inhibiting angiogenesis, tumor growth, and metastasis.
    Type: Grant
    Filed: May 8, 2008
    Date of Patent: July 27, 2010
    Assignee: Cell Matrix, Inc.
    Inventors: Jeffry D. Watkins, William D. Huse, Ying Tang, Daniel Broek, Peter Brooks
  • Patent number: 7763247
    Abstract: The invention provides a grafted antibody, or functional fragment thereof, comprising one or more complementarity determining regions (CDRs) having at least one amino acid substitution in one or more CDRs of a heavy chain CDR, where the grafted antibody or functional fragment thereof has specific binding activity for a cryptic collagen epitope. The invention also provides methods of using an antibody having specific binding activity for a cryptic collagen epitope, including methods of inhibiting angiogenesis, tumor growth, and metastasis.
    Type: Grant
    Filed: February 15, 2008
    Date of Patent: July 27, 2010
    Assignee: Cell Matrix, Inc.
    Inventors: Jeffry D. Watkins, William D. Huse, Ying Tang, Daniel Broek, Peter Brooks
  • Patent number: 7741909
    Abstract: A variable gain amplifier (VGA) with a gain thereof exponential to a control voltage thereof. The variable gain amplifier (VGA) comprises an exponential DC converter, and a linear voltage multiplier. The exponential DC converter receives the control voltage and generates an exponential voltage which is exponential to the control voltage. The linear voltage multiplier is coupled to the exponential DC converter and has a gain proportional to the exponential voltage of the exponential DC converter.
    Type: Grant
    Filed: April 14, 2008
    Date of Patent: June 22, 2010
    Assignee: Mediatek Singapore Pte Ltd
    Inventors: Yan Tong, Ying-Tang Chang
  • Patent number: 7740847
    Abstract: The present invention provides humanized anti-CD20 antibodies comprising a human IgG1 Fc region comprising an isoleucine at position 247 and a glutamine at position 339 as well as nucleic acids encoding the antibodies and methods of using the antibodies for treating lymphoma. Furthermore, the invention provides compositions comprising the antibodies and methods of producing them.
    Type: Grant
    Filed: July 18, 2005
    Date of Patent: June 22, 2010
    Assignee: Applied Molecular Evolution, Inc.
    Inventors: Barrett Allan, Weidong Jiang, Ying Tang, Jeffry Dean Watkins
  • Publication number: 20100040633
    Abstract: TGF-beta 1 binding compositions and reagents related thereto are provided. Methods of using such compositions for therapeutic purpose are also provided.
    Type: Application
    Filed: October 15, 2009
    Publication date: February 18, 2010
    Inventors: Julian Davies, Craig Duane Dickson, David Matthew Marquis, Ying Tang, Peter Edward Vaillancourt
  • Publication number: 20100005857
    Abstract: An Interactive Mobile Aquatic Probing and Surveillance system. The system includes a remote aquatic or amphibious agent which is controlled by a typically land-based computer host. The agent is a field robot in the form of a comparatively small and inexpensive, untethered, self-propelled, aquatic or amphibious, non-submersible vehicle that preferably carries physical and water characteristic sensors, as well as other operational equipment for use on relatively small bodies of water and wetlands. The host interacts with a human operator and provides control commands to and receives data from the agent in real time via a wireless communication between the agent and the host. The control commands include guidance commands including navigational and propulsion commands as well as commands for operating the sensors and various other equipment carried by the agent.
    Type: Application
    Filed: April 27, 2007
    Publication date: January 14, 2010
    Applicant: Rowan University
    Inventors: Hong Zhang, Ying Tang, Patricia Mosto, Courtney E. Richmond
  • Publication number: 20090297505
    Abstract: The present invention encompasses isolated antibodies, or fragments thereof, that are humanized variants of murine antibody 266 which employ complementarily determining regions derived from murine antibody 266. The variant antibodies are useful for treatment or prevention of conditions and diseases associated with A?, including Alzheimer's disease. Down's syndrome, cerebral amyloid angiopathy, mild cognitive impairment, and the like.
    Type: Application
    Filed: July 17, 2009
    Publication date: December 3, 2009
    Inventors: Julian Davies, Ying Tang, Jeffry Dean Watkins
  • Patent number: 7619069
    Abstract: TGF-beta 1 binding compositions and reagents related thereto are provided. Methods of using such compositions for therapeutic purpose are also provided.
    Type: Grant
    Filed: October 19, 2007
    Date of Patent: November 17, 2009
    Assignee: Eli Lilly and Company
    Inventors: Julian Davies, Craig Duane Dickinson, David Matthew Marquis, Ying Tang, Peter Edward Vaillancourt
  • Publication number: 20090256635
    Abstract: A variable gain amplifier (VGA) with a gain thereof exponential to a control voltage thereof. The variable gain amplifier (VGA) comprises an exponential DC converter, and a linear voltage multiplier. The exponential DC converter receives the control voltage and generates an exponential voltage which is exponential to the control voltage. The linear voltage multiplier is coupled to the exponential DC converter and has a gain proportional to the exponential voltage of the exponential DC converter.
    Type: Application
    Filed: April 14, 2008
    Publication date: October 15, 2009
    Applicant: MEDIATEK SINGAPORE PTE LTD.
    Inventors: Yan Tong, Ying-Tang Chang
  • Patent number: 7575747
    Abstract: The present invention encompasses isolated antibodies, or fragments thereof, that are humanized variants of murine antibody 266 which employ complementarity determining regions derived from murine antibody 266. The variant antibodies are useful for treatment or prevention of conditions and diseases associated with A?, including Alzheimer's disease, Down's syndrome, cerebral amyloid angiopathy, mild cognitive impairment, and the like.
    Type: Grant
    Filed: February 6, 2004
    Date of Patent: August 18, 2009
    Assignee: Applied Molecular Evolution
    Inventors: Julian Davies, Ying Tang, Jeffry Dean Watkins
  • Patent number: 7566770
    Abstract: The invention provides an antibody, or functional fragment thereof, a grafted antibody, or functional fragment thereof, comprising one or more complementarity determining regions (CDRs) having at least one amino acid substitution in one or more CDRs of a heavy chain CDR, where the antibody or functional fragment thereof has specific binding activity for a cryptic collagen epitope. The invention also provides methods of using an antibody having specific binding activity for a cryptic collagen epitope, including methods of inhibiting angiogenesis, tumor growth, and metastasis.
    Type: Grant
    Filed: July 14, 2006
    Date of Patent: July 28, 2009
    Assignee: Cell-Matrix, Inc.
    Inventors: Jeffry D. Watkins, William D. Huse, Ying Tang, Daniel Broek, Peter Brooks
  • Publication number: 20090136495
    Abstract: Monoclonal antibodies are provided that selectively bind human hepcidin-25 and are characterized as having high affinity for human hepcidin-25 and strong human mature hepcidin neutralizing properties. The antibodies of the invention are useful therapeutically for increasing serum iron levels, reticulocyte count, red blood cell count, hemoglobin, and/or hematocrit in a human and for the treatment and diagnosis of mature hepcidin-promoted disorders such as anemia, in a human subject.
    Type: Application
    Filed: October 29, 2008
    Publication date: May 28, 2009
    Inventors: Dennis Patrick Gately, Donmienne Doen Mun Leung, Barbara Anne Swanson, Ying Tang, YuPing Anthony Cai, LuHong He, Peng Luan, Derrick Ryan Witcher
  • Publication number: 20090047277
    Abstract: The present invention provides novel antibodies that immunospecifically bind to an IL-9 polypeptide and compositions comprising said antibodies. The present invention also provides methods and compositions preventing, treating, managing, and/or ameliorating diseases and disorders associated with aberrant expression and/or activity of IL 9 or IL-9 receptor or subunits thereof, autoimmune diseases, inflammatory diseases, proliferative diseases, and infections comprising administration of one or more antibodies thereof that immunospecifically bind to an IL-9 polypeptide. The invention also encompasses methods and compositions for diagnosing, monitoring, and prognosing these disorders. The present invention further relates to articles of manufacture and kits comprising antibodies that immunospecifically bind to an IL-9 polypeptide.
    Type: Application
    Filed: June 27, 2007
    Publication date: February 19, 2009
    Applicant: MEDIMMUNE, INC.
    Inventors: Jennifer Lynne REED, Herren Wu, Ying Tang, Julian Davies, Jeffry D. Watkins
  • Publication number: 20080296340
    Abstract: A dual-use nail magazine for alternatively accommodating a T-shaped nail strip or an inverted U-shaped nail strip includes a track bar defining a first channel for receiving the T-shaped nail strip when it is used alone, a second channel, and a third channel cooperated with the first channel for receiving the inverted U-shaped nail strip. A nail pushing mechanism has a rod member suspended in the second channel, a nail push plate movably sleeved onto the rod member and having a first nail-pushing portion inserted into the first channel, and a second nail-pushing portion inserted into the third channel, and a compression spring sleeved onto the rod member for supporting and moving the nail pusher along the first channel and the third channel so as to push the T-shaped nail strip in the first channel or the inverted U-shaped nail strip in the first and third channels.
    Type: Application
    Filed: August 27, 2007
    Publication date: December 4, 2008
    Applicant: MOBILETRON ELECTRONICS CO., LTD.
    Inventor: Ying-Tang Wang
  • Publication number: 20080260733
    Abstract: The invention provides a grafted antibody, or functional fragment thereof, comprising one or more complementarity determining regions (CDRs) having at least one amino acid substitution in one or more CDRs of a heavy chain CDR, where the grafted antibody or functional fragment thereof has specific binding activity for a cryptic collagen epitope. The invention also provides methods of using an antibody having specific binding activity for a cryptic collagen epitope, including methods of inhibiting angiogenesis, tumor growth, and metastasis.
    Type: Application
    Filed: May 8, 2008
    Publication date: October 23, 2008
    Applicant: CELLMATRIX
    Inventors: Jeffry D. Watkins, William D. Huse, Ying Tang, Daniel Broek, Peter Brooks
  • Publication number: 20080233133
    Abstract: The invention provides a grafted antibody, or functional fragment thereof, comprising one or more complementarity determining regions (CDRs) having at least one amino acid substitution in one or more CDRs of a heavy chain CDR, where the grafted antibody or functional fragment thereof has specific binding activity for a cryptic collagen epitope. The invention also provides methods of using an antibody having specific binding activity for a cryptic collagen epitope, including methods of inhibiting angiogenesis, tumor growth, and metastasis.
    Type: Application
    Filed: February 15, 2008
    Publication date: September 25, 2008
    Applicant: Cell Matrix, Inc.
    Inventors: Jeffry D. Watkins, William D. Huse, Ying Tang, Daniel Broek, Peter Brooks
  • Patent number: 7395035
    Abstract: An up-conversion mixing system with high carrier suppression, which includes first and second LPFs to filter a first and a second input signals to thereby produce a first and a second filtered signals respectively; a first amplifier to amplify the first input signal and the first filtered signal to thereby produce a first amplified signal; a second amplifier to amplify the second input signal and the second filtered signal to thereby produce a second amplified signal, wherein the second amplifier is cross-coupled with the first amplifier in order to couple the first and the second amplified signals, thereby reducing a DC offset of a differential voltage output by the first and the second differential output terminals; and a switch to receive a differential local oscillation signal to shift the first and the second amplified signals up to frequencies associated with the local oscillation signal.
    Type: Grant
    Filed: April 21, 2006
    Date of Patent: July 1, 2008
    Assignee: Sunplus Technology Co., Ltd.
    Inventors: Yao-Chi Wang, Ying-Tang Chang
  • Patent number: 7390885
    Abstract: The invention provides a grafted antibody, or functional fragment thereof, comprising one or more complementarity determining regions (CDRs) having at least one amino acid substitution in one or more CDRs of a heavy chain CDR, where the grafted antibody or functional fragment thereof has specific binding activity for a cryptic collagen epitope. The invention also provides methods of using an antibody having specific binding activity for a cryptic collagen epitope, including methods of inhibiting angiogenesis, tumor growth, and metastasis.
    Type: Grant
    Filed: December 6, 2001
    Date of Patent: June 24, 2008
    Assignee: Cell Matrix, Inc.
    Inventors: Jeffry D. Watkins, William D. Huse, Ying Tang, Daniel Broek, Peter Brooks